| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 6 | +66.67% | -5.40% | +0.87% | -6.26% | -4.76% | — |
| 14d | 6 | +50.00% | -8.33% | +1.88% | -10.20% | -1.89% | — |
| 30d | 6 | +66.67% | -4.15% | +2.65% | -6.80% | -5.76% | — |
| 60d | 6 | +66.67% | -10.19% | -0.13% | -10.05% | -14.27% | — |
| 90d | 6 | +50.00% | -8.93% | +1.75% | -10.69% | -10.36% | — |
| 180d | 6 | +83.33% | +51.05% | +12.26% | +38.78% | -41.46% | — |
| 1y | 6 | +50.00% | +17.34% | +21.69% | -4.36% | -24.11% | — |
| 2y | 6(1 pending) | +80.00% | -43.96% | +44.93% | -88.89% | -102.51% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| LYEL LYELL IMMUNOPHARMA, INC. | SALE Chief Medical Officer | 1,977 | $12.64 | $25.0K | 20,923 | Jun 10, 2026 | Jun 11, 2026 ↗ | View → |
| LYEL LYELL IMMUNOPHARMA, INC. | PURCHASEGRANT Stock grant | 50,000 | — | — | 50,000 | Feb 10, 2026 | Feb 11, 2026 ↗ | View → |
| LYEL LYELL IMMUNOPHARMA, INC. | PURCHASEGRANT Stock grant | 21,900 | — | — | 21,900 | Jun 9, 2025 | Jun 11, 2025 ↗ | View → |
| LYEL LYELL IMMUNOPHARMA, INC. | PURCHASEGRANT Stock grant | 43,750 | — | — | 43,750 | Jun 9, 2025 | Jun 11, 2025 ↗ | View → |
| NKTX NKARTA, INC. | SALE See Remarks | 8,638 | $2.20 | $19.0K | 190,955 | Jan 15, 2025 | Jan 17, 2025 ↗ | View → |
| NKTX NKARTA, INC. | PURCHASEGRANT Stock grant | 59,000 | — | — | 199,593 | Jan 3, 2025 | Jan 7, 2025 ↗ | View → |
| NKTX NKARTA, INC. | PURCHASEGRANT Stock grant | 117,500 | — | — | 117,500 | Jan 3, 2025 | Jan 7, 2025 ↗ | View → |
| NKTX NKARTA, INC. | SALEGRANT Stock grant | 1,352 | $5.11 | $6.9K | 138,593 | Aug 21, 2024 | Aug 23, 2024 ↗ | View → |
| NKTX NKARTA, INC. | PURCHASEGRANT Stock grant | 30,000 | — | — | 30,000 | Jul 15, 2024 | Jul 31, 2024 ↗ | View → |
| NKTX NKARTA, INC. | PURCHASEGRANT Stock grant | 23,421 | — | — | 139,945 | Jul 15, 2024 | Jul 31, 2024 ↗ | View → |
| NKTX NKARTA, INC. | SALE Chief Medical Officer | 456 | $5.60 | $2.6K | 116,524 | Jun 18, 2024 | Jun 20, 2024 ↗ | View → |
| NKTX NKARTA, INC. | SALE Chief Medical Officer | 3,552 | $8.74 | $31.0K | 114,980 | Jan 16, 2024 | Jan 18, 2024 ↗ | View → |
| NKTX NKARTA, INC. | PURCHASEGRANT Stock grant | 112,500 | — | — | 112,500 | Jan 4, 2024 | Jan 8, 2024 ↗ | View → |
| NKTX NKARTA, INC. | PURCHASEGRANT Stock grant | 56,000 | — | — | 118,532 | Jan 4, 2024 | Jan 8, 2024 ↗ | View → |
| NKTX NKARTA, INC. | SALE Chief Medical Officer | 1,331 | $1.83 | $2.4K | 60,532 | Aug 21, 2023 | Aug 23, 2023 ↗ | View → |
| NKTX NKARTA, INC. | PURCHASEGRANT Stock grant | 208,000 | — | — | 208,000 | Jul 1, 2023 | Jul 5, 2023 ↗ | View → |
| NKTX NKARTA, INC. | SALE Chief Medical Officer | 439 | $4.85 | $2.1K | 61,863 | Jun 20, 2023 | Jun 22, 2023 ↗ | View → |
| NKTX NKARTA, INC. | SALE Chief Medical Officer | 175 | $5.49 | $961 | 60,302 | Jan 17, 2023 | Jan 18, 2023 ↗ | View → |
| NKTX NKARTA, INC. | PURCHASEGRANT Stock grant | 75,000 | — | — | 75,000 | Jan 13, 2023 | Jan 18, 2023 ↗ | View → |
| NKTX NKARTA, INC. | PURCHASEGRANT Stock grant | 37,500 | — | — | 60,477 | Jan 13, 2023 | Jan 18, 2023 ↗ | View → |